Trial intelligence / Profile preview

L-arginine and Glutamine Supplementation in Preterm Neonates

NCT01263041Phase 3Completed

Sponsor
Ain Shams University
Start
May 2011
Primary completion
Feb 2014
Modality
Recombinant Proteins and Enzymes, Orthosteric Ligands, Peptides
Countries
1
01

Overview

A Phase 3 trial of arginine, glutamine in necrotizing enterocolitis (NEC), sepsis, sponsored by Ain Shams University. Started May 2011; status: completed.

02

Drugs

arginineglutamine
03

Conditions

necrotizing enterocolitis (NEC)sepsis

Beyond the preview

Go deeper on NCT01263041.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01263041.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call